Smashed: Here's why shares in OrotonGroup Limited dived 20% today

After a strong-ish year in 2016, OrotonGroup Limited (ASX:ORL) appears to have lost all the ground it previously gained.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in clothier OrotonGroup Limited (ASX: ORL) have fallen further today, losing 21% to $1.67 after the company announced a further update to the negative sales first reported at its Annual General Meeting (AGM) last year.

Like-For-Like ("LFL") sales have materially worsened, from being down 8% at the time of the AGM last year, to being down 10% now with just two weeks remaining in the first half of the year. Curiously, OrotonGroup LFL sales were up 10% at the same time last year, suggesting the company has lost most of the ground it gained.

A weak women's range and more aggressive discounting from competitors was identified as a key contributor to weaker sales. Sales in the GAP brand fell hard, down 11% compared to a 6% increase at the same time last year. Core Oroton brand sales seemingly improved from last year, with LFL sales excluding discontinued categories 'continuing to be positive against strong LFL store sales from last year of +11%'. How positive these sales were was not specified.

The first half is now expected to deliver Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) of between $4.5 million and $5.0 million, down approximately 40% from $8.9 million in the first half of 2016.

Curiously, management pointed out that 2016's $8.9 million was 25% above 2015's first half result of $7.1 million. This shows that Oroton's first half was extraordinarily weak, the worst result since before 2014.

Foolish Takeaway

Oroton looks cheap on the face of it, but its worsening results and comments about competition show that it will likely cost investors more than it will make them. When fierce competition is the primary reason for the weakest first-half result in more than 3 years, that is a sign that it is not time to buy this company.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »